Nobody knows what LLMab does outside of binding to
Post# of 148250
But The Bruce Patterson did identify a difficult to explain drop in circulating SARS2 virions. Whether it's LLMab directly or indirectly (by immune modulation) acting on the virions, it (according to BP) absolutely effects the virus (and thus, the course of disease).
This all depends on what you think of BP's findings.